Dubai approves 10-week interval between 1st and 2nd dose of Oxford-AstraZeneca vaccine for COVID-19

Dubai approves 10-week interval between 1st and 2nd dose of Oxford-AstraZeneca vaccine for COVID-19

The Dubai Health Authority (DHA) said that there would be a 10-week interval between the 1st and 2nd dose of the Oxford-AstraZeneca vaccine for COVID-19. The DHA revealed this on its social media platforms, "Recent studies from the University of Oxford on the Oxford-AstraZeneca vaccine showed a higher efficacy and higher acquired immunity when the interval between the first and second dose was increased. "Based on this study and recommendations of the World Health Organisation, DHA has approved a 10-week interval between the first and the second dose of the Oxford-AstraZeneca vaccine." The DHA also said, "All those who are due for the second dose of this vaccine will receive a text message with the date and location for their vaccination appointment." The authorisation of COVID-19 Vaccine AstraZeneca manufactured by AstraZeneca, and COVISHIELD manufactured by Serum Institute of India (SII), enables global access to the vaccine during the pandemic. The EUL allows for two doses of the vaccine to be administered at a four to 10-week interval. This regimen was shown in clinical trials to be safe and effective in preventing symptomatic COVID-19, with no severe cases and no hospitalisations more than 14 days after the second dose. The WHO's